Literature DB >> 21545240

Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction.

Xinyu Wang1, Shunlin Xu, Ying Liang, Dan Zhu, Lin Mi, Guisong Wang, Wei Gao.   

Abstract

Acute myocardial infarction (AMI) is characterized by complex neuroendocrine activation. To investigate catestatin profiles, serial catestatin levels were determined by enzyme-linked immunosorbent assay in the first week after AMI in 50 patients. Catestatin levels reduced at admission and negatively correlated with heart rates; it increased significantly on the third day but remained decreased at 1 week and positively with blood pressure. In a subgroup of 20 patients admitted within 4 h after onset, circulating catestatin correlated inversely with norepinephrine. Catestatin might be involved in the course of AMI and act as a tool in monitoring the progression of AMI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21545240     DOI: 10.3109/1354750X.2011.578260

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  10 in total

1.  Increased plasma level of catestatin might be associated with poor prognosis in hemodialysis patients.

Authors:  Huaibin Sun; Wanhua Xian; Lina Geng; Engang Li; Zhiguo Peng; Jun Tian
Journal:  Int Urol Nephrol       Date:  2017-02-04       Impact factor: 2.370

Review 2.  Role of Catestatin in the Cardiovascular System and Metabolic Disorders.

Authors:  Ewa Zalewska; Piotr Kmieć; Krzysztof Sworczak
Journal:  Front Cardiovasc Med       Date:  2022-05-19

3.  Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.

Authors:  Maria-Giulia Perrelli; Francesca Tullio; Carmelina Angotti; Maria Carmela Cerra; Tommaso Angelone; Bruno Tota; Giuseppe Alloatti; Claudia Penna; Pasquale Pagliaro
Journal:  Pflugers Arch       Date:  2013-01-15       Impact factor: 3.657

Review 4.  Circulating chromogranin A and its fragments as diagnostic and prognostic disease markers.

Authors:  Angelo Corti; Fabrizio Marcucci; Tiziana Bachetti
Journal:  Pflugers Arch       Date:  2017-10-10       Impact factor: 3.657

5.  An analysis of patients receiving emergency CAG without PCI and the value of GRACE score in predicting PCI possibilities in NSTE-ACS patients.

Authors:  Bo-Da Zhou; Ling-Yun Zu; Lin Mi; Gui-Song Wang; Li-Jun Guo; Wei Gao
Journal:  J Geriatr Cardiol       Date:  2015-05       Impact factor: 3.327

6.  Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).

Authors:  Supranee Jitpean; Mats Stridsberg; Ann Pettersson; Odd V Höglund; Bodil Ström Holst; Ragnvi Hagman
Journal:  BMC Vet Res       Date:  2015-01-31       Impact factor: 2.741

7.  Plasma Catestatin: A Useful Biomarker for Coronary Collateral Development with Chronic Myocardial Ischemia.

Authors:  Weixian Xu; Haiyi Yu; Weihong Li; Wei Gao; Lijun Guo; Guisong Wang
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

8.  Catestatin prevents endothelial inflammation and promotes thrombus resolution in acute pulmonary embolism in mice.

Authors:  Hua Chen; Dongxia Liu; Lan Ge; Tao Wang; Zhenzhen Ma; Yuping Han; Yawei Duan; Xin Xu; Wei Liu; Jing Yuan; Jing Liu; Ruyi Li; Rongpin Du
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

9.  Catestatin attenuates endoplasmic reticulum induced cell apoptosis by activation type 2 muscarinic acetylcholine receptor in cardiac ischemia/reperfusion.

Authors:  Feng Liao; Yang Zheng; Junyan Cai; Jinghui Fan; Jing Wang; Jichun Yang; Qinghua Cui; Guoheng Xu; Chaoshu Tang; Bin Geng
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

10.  Plasma Catestatin Levels and Advanced Glycation End Products in Patients on Hemodialysis.

Authors:  Mirko Luketin; Maja Mizdrak; Dijana Boric-Skaro; Dinko Martinovic; Daria Tokic; Marino Vilovic; Daniela Supe-Domic; Tina Ticinovic Kurir; Josko Bozic
Journal:  Biomolecules       Date:  2021-03-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.